MarketCap
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
2015 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ CAPITAL |
Anteile |
889 K |
Marktkapitalisierung |
$ 1.06 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
IQVIA Holdings
IQV
|
$ 265.11 | 0.5 % | $ 45.6 B | NYSE,SPB | USA |
 |
Anixa Biosciences
ANIX
|
$ 3.01 | -8.23 % | $ 97.7 K | Nasdaq Capital Market | USA |
 |
Biodesix
BDSX
|
$ 19.8 | -7.86 % | $ 150 M | Nasdaq Global Market | USA |
 |
BioNano Genomics
BNGO
|
$ 1.12 | -6.3 % | $ 6.1 M | Nasdaq Capital Market,SPB | USA |
 |
Bioventus
BVS
|
$ 10.65 | -6.74 % | $ 710 M | Nasdaq Global Select Market | USA |
 |
IDEXX Laboratories
IDXX
|
$ 670.93 | -3.95 % | $ 54 B | Nasdaq Global Select Market,SPB | USA |
 |
Fulgent Genetics
FLGT
|
$ 18.63 | -5.34 % | $ 573 M | Nasdaq Global Market | USA |
 |
CareDx, Inc
CDNA
|
$ 76.31 | -11.13 % | $ 4.07 B | Nasdaq Global Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Biomerica
BMRA
|
$ 1.61 | -7.2 % | $ 4.69 M | Nasdaq Capital Market | USA |
 |
Interpace Biosciences
IDXG
|
$ 7.0 | 22.38 % | $ 31 M | Nasdaq Global Select Market | USA |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
ICON Public Limited Company
ICLR
|
$ 201.41 | -0.84 % | $ 15.8 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Co-Diagnostics
CODX
|
$ 0.27 | -24.13 % | $ 359 K | Nasdaq Capital Market | USA |
 |
Burning Rock Biotech Limited
BNR
|
$ 13.26 | 3.35 % | $ 139 M | Nasdaq Global Market |  China |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
DarioHealth Corp.
DRIO
|
$ 2.74 | -7.74 % | $ 10.9 M | Nasdaq Capital Market |  Israel |
 |
QIAGEN N.V.
QGEN
|
$ 50.87 | 0.11 % | $ 11 B | NYSE |  Niderland |
 |
Myriad Genetics
MYGN
|
$ 6.29 | 4.49 % | $ 582 M | Nasdaq Global Select Market,SPB | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 5.01 | 1.32 % | $ 3.94 M | Nasdaq Global Select Market | USA |
 |
NeoGenomics
NEO
|
$ 16.48 | -3.91 % | $ 2.11 B | Nasdaq Global Select Market,SPB | USA |
 |
OPKO Health
OPK
|
$ 1.75 | -1.41 % | $ 1.31 B | Nasdaq Global Select Market | USA |
 |
Pacific Biosciences of California
PACB
|
$ 2.42 | -4.9 % | $ 726 M | Nasdaq Global Select Market,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 11.67 | -6.38 % | $ 2.54 B | Nasdaq Global Select Market,SPB | USA |
 |
Precipio
PRPO
|
$ 18.57 | -5.11 % | $ 29.8 M | Nasdaq Global Select Market | USA |
 |
Personalis
PSNL
|
$ 15.53 | -1.65 % | $ 1.39 B | Nasdaq Global Select Market | USA |
 |
Quidel Corporation
QDEL
|
$ 12.82 | -10.7 % | $ 540 M | Nasdaq Global Select Market,SPB | USA |
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Guardant Health
GH
|
$ 154.56 | -8.32 % | $ 19.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | Israel |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 25.49 | -5.84 % | $ 571 M | Nasdaq Global Select Market | USA |
 |
Twist Bioscience Corporation
TWST
|
$ 120.47 | -15.51 % | $ 7.21 B | Nasdaq Global Select Market,SPB | USA |
 |
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | USA |
 |
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | USA |
 |
PerkinElmer
PKI
|
- | -0.91 % | $ 14.7 B | NYSE,SPB | USA |
 |
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Agilent Technologies
A
|
$ 171.62 | -3.14 % | $ 48.7 B | NYSE,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 312.54 | -4.19 % | $ 15.5 B | NYSE,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 100.73 | -0.41 % | $ 6.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Natera
NTRA
|
$ 363.86 | -6.95 % | $ 49.7 B | Nasdaq Global Select Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 363.12 | -1.26 % | $ 30.2 B | NYSE,SPB | USA |
 |
Castle Biosciences
CSTL
|
$ 34.15 | -4.49 % | $ 990 M | Nasdaq Global Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 253.91 | -0.69 % | $ 28.2 B | NYSE,SPB | USA |